CCNG2 and ovarian cancer: We recently demonstrated that cyclin G2 exerts tumor-suppressive effects by inhibiting epithelial-to-mesenchymal transition (EMT) via suppression of Wnt/ß-catenin signaling in ovarian cancer cells [18].